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Abstract 
We present ultrastructural and biochemical evidence for the turnover of intact fibrillin microfibrils by the serine proteinases, neutrophil elastase, 
chymotrypsin and trypsin. Rotary shadowing electron microscopy revealed that serine proteinase treatment of intact microfibrils isolated from foetal 
bovine skin resulted in extensive degradation. Microfibrils were destroyed by neutrophil elastase and effectively disrupted by chymotrypsin and 
trypsin, with no morphologically identifiable arrays remaining. Evidence of defined fibrillin degradation products was obtained by Western blotting 
of these enzyme-treated fibrillin assemblies. Fibrillin immunoprecipitated from dermal fibroblast culture medium was also comprehensively degraded 
by these enzymes. These observations demonstrate that serine proteinases are potent effecters for the physiological and pathological catabolism of 
microfibrils, and suggest a key role in elastic fibre degradation. 
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1. Introduction 
The glycoprotein fibrillin is the major component of 
a class of extracellular microfibrils that are key determi- 
nants of connective tissue architecture and integrity [l- 
31. Characteristically these microfibrils have an average 
55 nm beaded periodicity and a diameter of 10-12 nm 
[4-61. The importance of these microfibrils was recently 
brought into close focus by the linkage of fibrillin genes 
on chromosomes 15 and 5 to the heritable connective 
tissue diseases Marfan syndrome (MFS), ectopia lentis 
(EL) and congenital contractural arachnodactyly (CCA) 
[7-91. 
Fibrillin microfibrils have a widespread istribution in 
connective tissues and are particularly abundant in elas- 
tic tissues such as aorta, ligament and skin where they 
form integral components of elastic fibres [I ,101. Ultra- 
structurally indistinguishable microfibrils are also pres- 
ent in many non-elastic tissues such as ocular zonular 
fibres, tendon and bone [4,5]. At present, the assumption 
is that fibrillin is the major component of all morpholog- 
ically identical microfibrils in both elastic and non-elastic 
tissues. 
Elastic fibres are deposited in tissues in a variety of 
structural forms [lo]. Studies on the early stages of elastic 
fibrillogenesis have all indicated that the bundles of mi- 
crofibrils which appear first within the matrix apparently 
define the development and organisation of elastic fibres 
[l]. They are retained in mature elastic fibres in the form 
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of a peripheral mantle surrounding the amorphous 
elastin core. 
Whilst details of microfibrillar involvement in elastin 
deposition are beginning to be unravelled, there is a pau- 
city of information about the fates of both components 
in the extracellular matrix. In normal circumstances, 
elastin has an exceptionally long biological half-life, and 
it appears that elastic fibres are likely to function for 
exceedingly long periods. The physiological mechanisms 
of elastic fibre degradation is not well defined. In some 
pathological circumstances, such as pulmonary emphy- 
sema, more rapid breakdown is seen, but it is not clear 
if this occurs by upregulation of the mechanisms in- 
volved in normal turnover, or by additional factors. The 
principal enzyme involved in elastin turnover appears to 
be elastase, a serine proteinase secreted by neutrophils 
[l 11. In addition, the matrix metalloproteinases (MMPs), 
stromelysin and gelatinase [ 12,131, produced by a variety 
of cell types, and the cysteine proteinase, cathepsin L 
[14,15], have all been implicated in elastin degradation. 
Further information about the enzyme susceptibility 
of elastic fibres came when attempts were made to isolate 
and separate microfibrillar proteins from elastin [16]. It 
was clear that both components were resistant o bacte- 
rial collagenase digestion, but when tissues were treated 
with a range of enzymes it appeared that elastin-associ- 
ated microfibrils and amorphous elastic tissue had differ- 
ent susceptibilities to enzymic digestion. Microfibrils 
could no longer be demonstrated after the tissue was 
digested with trypsin and chymotrypsin, although they 
appeared to be unaffected by elastase. In contrast, elastin 
was degraded by elastase but unaffected by trypsin and 
chymotrypsin [ 1,161. 
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The ability to isolate intact microfibrillar assemblies 
[6,17] has allowed us to examine in more detail the sus- 
ceptibility of elastic microfibrils to serine proteases. This 
report provides information about the action of neutro- 
phi1 elastase, trypsin and chymotrypsin on intact microfi- 
brillar assemblies, and implicates elastase as a key en- 
zyme in the turnover of the fibrillin microfibrils. 
2. Materials and methods 
Second trimester foetal calves were obtained from the local abattoir 
within 1 h of maternal death. Human neutrophil elastase was purified 
to homogeneity as previously described [18]. Bacterial collagenase (type 
1 A), chymotrypsin (EC 3.4.21 .I), trypsin (EC 3.4.21.4), pancreatic elas- 
tase (EC 3.4.21.7), phenylmethanesulphonyl fluoride (PMSF), N-eth- 
ylmaleimide (NEM), p-tosyl-L-lysine chloromethyl ketone (TLCK), 
N-tosyl-L-phenylalanine chloromethyl ketone (TPCK), diaminoben- 
zamidine, dithiothreitol, gelatine, Tween 20, peroxidase-conjugated 
goat anti-rabbit IgG and prestained molecular weight markers were 
obtained from the Sigma Chemical Co., Poole Dorset, UK. CNBr- 
activated Sepharose CL4B, protein A-Sepharose, and Sepharose CL- 
2B were supplied by Pharmacia-LKB, Milton Keynes, Bucks, UK. 
Enhanced chemiluminescence kits were supplied by Amersham Inter- 
national, Bucks, UK. 
Intact fibrillin microfibrils were isolated from foetal bovine skin as 
previously described [6,17]. This procedure involves disruption of tissue 
with mild bacterial collagenase digestion and isolation of high-M7 mi- 
crofibrils by gel filtration chromatography on Sepharose CL-2B. 
Enzyme: microfibril incubations were carried out in 0.05 M Tris-HCl, 
pH 7.4 containing 0.4 M NaCl and 0.01 M CaCl, for 1 h, 2 h and 16 
h at 22°C and 37°C. Microflbril preparations (diluted to a final concen- 
tration of 200 &ml) were incubated with 10 &ml, trypsin containing 
1 fig/ml TPCK, 10 @ml chymotrypsin containing 1 &ml TLCK, or 
with 4 pg neutrophil elastase in a final volume of 100 ~1. Enzyme 
reactions were stopped with PMSF (final concentration 2 mM). Ali- 
quots (10 ~1) were removed for ultrastructural analysis. Control and 
enzyme-treated microfibril preparations were analysed ultrastruc- 
turally by rotary shadowing electron microscopy as previously de- 
scribed [6,17]. The remainder of each treated aliquot was electrophor- 
esed on 8% SDS-PAGE gels under non-reducing conditions prior to 
Western blotting using a polyclonal anti-fibrillin [17,19-211. The pri- 
mary antiserum and a peroxidase-conjugated goat anti-rabbit IgG sec- 
ondary antibody were used at l:lO,OOO dilutions and detection was by 
enhanced chemiluminescence. 
Dermal fibroblasts (passage 4) were maintained in Dulbecco’s mini- 
mum essential medium supplemented with 10% foetal calf serum, pen- 
icillin (400 U/ml), streptomycin (50 mg/ml), and glutamine (200 mg/ml). 
Confluent cells were labelled with [“S]TranSlabel in medium containing 
0.5% foetal calf serum. Fibrillin was immunoprecipitated from medium 
as previously described (191. In view of the similar electrophoretic mo- 
bilities on SDS-PAGE of fibronectin and fibrillin, fibronectin was re- 
moved before immunoprecipitation of fibrillin by two sequential incu- 
bations of 100 ~1 1: 1(v/v) solution of gelatin-Sepharose. Samples were 
then incubated for 1 h at 20°C with a 1:lOO dilution of polyclonal 
anti-fibrillin serum [17,19-211 before the addition of 60 ~1 of a 1:l 
solution of protein A-Sepharose in 0.05 M Tris-HCI, pH 7.4, containing 
0.4 M NaCl and 1% (v/v) Nonidet P40. Immunoprecipitates were incu- 
bated for 16 h at 37°C in the presence or absence of IOpglml trypsin, 
chymotrypsin, or elastase, and then analysed irectly by electrophoresis 
on 8% SDS-PAGE gels under non-reducing conditions, and fluorogra- 
phy. 
3. Results 
3.1. Ultrastructural analysis 
Microfibrils incubated for 16 h at 22°C and 37°C 
remained intact, with abundant extensive fibrillin 
microfibrillar arrays clearly evident (Fig. 1A). Intact 
fibrillin microfibrils in solution were subjected to treat- 
ment at 22°C and 37°C with neutrophil elastase, chy- 
motrypsin and trypsin for 1 h, 2 h, 6 h and 16 h. Rotary 
shadowing electron microscopy demonstrated conclu- 
sively that all three enzymes were capable of degrading 
intact fibrillin microfibrils (Fig. 1). Elastase proved par- 
ticularly disruptive to mcirofibrils. Although microfibrils 
were detected after 1 h and 2 h incubations with elastase 
at 37°C it was clear that substantial disruption had 
already occurred (Fig. 1B). After short treatment at 
37°C degradation was more advanced than at 22°C. 
After 16 h at 22’C or 37°C few morphologically identi- 
fiable microfibrils remained, although extensive intact 
collagen fibres and type VI collagen microfibrils were 
evident (Fig. lC,D). Such incubations highlighted the 
susceptibility of the interbeaded regions to cleavage. 
Microfibrillar structure was also profoundly disrupted 
by chymotrypsin and trypsin (Fig. lE-H). The disruptive 
effects of these enzymes was already apparent on exami- 
nation of preparations after 2 h enzyme incubations at 
37°C (Fig. lE,G). After 16 h at 37°C very few short 
assemblies were still detectable within the treated sam- 
ples (Fig. lF,H). 
3.2. Biochemical analysis of effects of enzyme treatments 
The process of fibrillin degradation was investigated 
by Western blotting of high-M, assemblies from foetal 
bovine skin treated with elastase, trypsin or chymotryp- 
sin in time course experiments (Fig. 2). This approach 
highlighted the occurrence of several defined intermedi- 
ates of fibrillin degradation in the &f, range 40-65 kDa 
as well as small fragments which migrated at or near the 
dye front. 
Immunoprecipitated fibrillin from dermal fibroblast 
culture medium was treated at 37°C with elastase, chy- 
motrypsin and trypsin for 16 h and then analysed by 
SDS-PAGE and fluorography (Fig. 3). Intact fibrillin 
monomers (M, 300,000) had been comprehensively de- 
graded by all three enzymes, and after 16 h no intact 
fibrillin remained. Enhanced levels of a smaller fibrillin- 
immunoreactive component (Mr 55,000) apparent in the 
undigested control, were detected in the trypsin- and 
chymotrypsin-treated immunoprecipitates, but this pol- 
ypeptide was degraded by elastase. In addition, small 
fragments migrating with the dye front were detected in 
the three enzyme treated samples. 
4. Discussion 
Fibrillin microfibrils are essential structural compo- 
nents of connective tissues, and play a key role in main- 
taining tissue integrity and functionality. Despite their 
importance in matrix organisation, nothing is known to 
date about microfibril turnover in vivo. We present the 
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I. Electron micrographs after rotary shadowing of fibrillin microfibrils isolated from foetal bovine skin [6,171. Fibrillin assemblies 
Bgnised by their distinctive beaded appearance. Microfibril preparations were treated with neutrophil elastase (B,C) or pancreatic 
tsin (E,F) and chymotrypsin (G,H) for 2 h or 16 h at 37°C. Arrows highlight disrupted interbeaded omains. The micrograpt 
representative of all fields examined. Bars = 100 nm. 
first evidence that intact microfibrils are effectively cat- 
abolised in vitro by the serine proteases neutrophil elas- 
tase, chymotrypsin and trypsin. 
Neutrophil elastase is a serine proteinase of the pri- 
mary (azurophilic) granules of neutrophils. It is released 
upon activation and is purported to be essential for mi- 
gration of neutrophils through connective tissues [22]. 
It is a major degradative enzyme of neutrophils and 
is known to compromise the integrity of the extracellu- 
lar matrix especially at sites of ulceration or inflamma- 
tion. 
Tissue integrity is dependent upon an appropriate bal- 
ance between proteolytic activities required for normal 
tissue remodelling, and their inhibitors. The array of 
matrix-degrading proteinases and inhibitors is extensive. 
The most abundant plasma serine protease inhibitor is 
i were clc :arly 
elastase (D), 
IS showI;  are 
a,-antitrypsin [23], and it is interesting to note that CQ- 
antitrypsin deficiency is associated with abnormally 
rapid degradation of lung elastin leading to emphysema 
[24]. It has recently been shown that thrombospondin is 
a potent inhibitor of neutrophil elastase, and may serve 
as a regulator of enzyme activity in localised inflamma- 
tory reactions [25]. Inappropriate control of elastase ac- 
tivity is believed to be integral to the pathogenesis of 
pulmonary emphysema, acute respiratory disease, rheu- 
matoid arthritis, Crohn’s disease and other inflamma- 
tory conditions [22]. 
The observation that fibrillin microfibrils and mono- 
mers are degraded by neutrophil elastase has major im- 
plications for elastic fibre stability, function and turno- 
ver in physiological and pathological conditions. It is not 
clear whether the elastase-susceptible immunoreactive 
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A4,55,000 component represents a stable product of nor- 
mal fibrillin turnover or a microfibril-associated mole- 
cule. In inflammatory conditions where high levels of 
neutrophil elastase activity are found, fibrillin microfi- 
brils which form the outer mantle of elastic fibres are 
likely to be rapidly removed, thereby exposing the elastin 
core to the further degradative ffects of neutrophil elas- 
tase. Such a sequence of events possibly underlies the 
extensive lastic fibre damage classically associated with 
many inflammatory conditions. 
Mr X :103 230 
190 
The demonstration that three serine proteinases are 
capable of degrading fibrillin microfibrils suggests a gen- 
eral susceptibility o this class of enzyme. In addition to 
degrading defined elements of the matrix, the serine pro- 
teases are also implicated as key components of an inter- 
dependent mechanism leading to activation of the matrix 
metalloproteinase precursors [26]. The presence of neu- 
trophils, macrophages and mast cells in early inflamma- 
tory lesions provides a source of serine proteinases neces- 
sary for the breakdown of fibrillin and elastin, as well as 
contributing to the activation of metalloproteinases in- 
volved in the degradation of other matrix components. 
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Fig. 3. Electrophoretic analysis of fibrillin immunoprecipitated from 
medium of normal human dermal fibroblasts. Cells were labelled with 
[“‘S]TranSlabel for 16 h. Immunoprecipitates were incubated at 37°C 
overnight in the presence or absence of trypsin (IO@ml), chymotryp- 
sin (10 pg/ml) or elastase (10 &ml). Samples were analysed by SDS- 
PAGE on 8% gels under non-reducing conditions and by Auorography. 
The electrophoretic mobihties of molecular weight markers catalase 
(M, 232,000) and a,-macroglobulin (Mr 190,000) are indicated. Track 
1, untreated control; track 2, trypsin-treated; track 3, chymotrypsin- 
treated; track 4, elastase-treated. Arrows highlight degradation prod- 
ucts of trypsin and chymotrypsin. An M, 55,000 fibrillin-immunoreac- 
tive component was present in untreated immunoprecipitates and in 
increased amounts after trypsin and chymotrypsin treatment, but was 
clearly degraded by elastase. Low-M, fragments migrating with the dye 
front were also apparent in all the enzyme-treated samples. 
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Fig. 2. Western blotting of enzyme-treated fibrillin assemblies isolated 
from foetal bovine skin. High-M, assemblies were incubated at 37°C 
for 2 h or 6 h in the presence or absence of elastase, chymotrypsin or 
trypsin, prior to electrophoresis on 8% SDS-PAGE gels under non- 
reducing conditions. Western blotting was carried out using a polyclo- 
nal anti-fibrillin serum [17,19-211 and detection was by enhanced chem- 
iluminescence. The electrophoretic mobilities of molecular weight 
markers a,-macroglobulin (Mr 190,000) and /I-galactosidase (Mr 
125,000) are indicated. Tracks 14 are stained with Coomassie brilliant 
blue; tracks 5-10 are Western blots. Track 1, untreated high-M, frac- 
tion isolated from foetal bovine skin after bacterial collagenase diges- 
tion and size-fractionation. Fibrillin is present within this fraction. 
Tracks 24 contain the enzymes used in the digestions (track 3, elastase; 
track 4, chymotrypsin; track 5, trypsin). Tracks 5, 7 and 9 are 2 h 
digestions and tracks 6, 8 and 10 are 6 h digestions. Tracks 5 and 6, 
elastase-treated; tracks 7 and 8, chymotrypsin-treated; tracks 9 and 10, 
trypsin-treated. Defined fibrillin degradation products of all three en- 
zymes were detected. 
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